Otamixaban

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameOtamixaban
Drug Alias Name奥米沙班OtamixabanumFXV-673XRP-0673XRP-0673A +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsCoronary DiseaseAcute Coronary SyndromeRenal Insufficiency +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[57] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsCoronary DiseaseAcute Coronary SyndromeRenal Insufficiency +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia